These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 22791805)

  • 1. Compensatory molecular and functional mechanisms in nervous system of the Grm1(crv4) mouse lacking the mGlu1 receptor: a model for motor coordination deficits.
    Rossi PI; Musante I; Summa M; Pittaluga A; Emionite L; Ikehata M; Rastaldi MP; Ravazzolo R; Puliti A
    Cereb Cortex; 2013 Sep; 23(9):2179-89. PubMed ID: 22791805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic inactivation of mGlu5 receptor improves motor coordination in the Grm1
    Bossi S; Musante I; Bonfiglio T; Bonifacino T; Emionite L; Cerminara M; Cervetto C; Marcoli M; Bonanno G; Ravazzolo R; Pittaluga A; Puliti A
    Neurobiol Dis; 2018 Jan; 109(Pt A):44-53. PubMed ID: 28982591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presynaptic mGlu1 and mGlu5 autoreceptors facilitate glutamate exocytosis from mouse cortical nerve endings.
    Musante V; Neri E; Feligioni M; Puliti A; Pedrazzi M; Conti V; Usai C; Diaspro A; Ravazzolo R; Henley JM; Battaglia G; Pittaluga A
    Neuropharmacology; 2008 Sep; 55(4):474-82. PubMed ID: 18625255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The HIV-1 viral protein Tat increases glutamate and decreases GABA exocytosis from human and mouse neocortical nerve endings.
    Musante V; Summa M; Neri E; Puliti A; Godowicz TT; Severi P; Battaglia G; Raiteri M; Pittaluga A
    Cereb Cortex; 2010 Aug; 20(8):1974-84. PubMed ID: 20034999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic characterization of Grm1
    Musante I; Mattinzoli D; Otescu LA; Bossi S; Ikehata M; Gentili C; Cangemi G; Gatti C; Emionite L; Messa P; Ravazzolo R; Rastaldi MP; Riccardi D; Puliti A
    Bone; 2017 Jan; 94():114-123. PubMed ID: 27989650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Switch in the expression of mGlu1 and mGlu5 metabotropic glutamate receptors in the cerebellum of mice developing experimental autoimmune encephalomyelitis and in autoptic cerebellar samples from patients with multiple sclerosis.
    Fazio F; Notartomaso S; Aronica E; Storto M; Battaglia G; Vieira E; Gatti S; Bruno V; Biagioni F; Gradini R; Nicoletti F; Di Marco R
    Neuropharmacology; 2008 Sep; 55(4):491-9. PubMed ID: 18619983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
    Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type-1, but Not Type-5, Metabotropic Glutamate Receptors are Coupled to Polyphosphoinositide Hydrolysis in the Retina.
    Romano MR; Di Menna L; Scarselli P; Mascio G; Madonna M; Notartomaso S; Puliti A; Bruno V; Battaglia G; Nicoletti F
    Neurochem Res; 2016 Apr; 41(4):924-32. PubMed ID: 26700429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. crv4, a mouse model for human ataxia associated with kyphoscoliosis caused by an mRNA splicing mutation of the metabotropic glutamate receptor 1 (Grm1).
    Conti V; Aghaie A; Cilli M; Martin N; Caridi G; Musante L; Candiano G; Castagna M; Fairen A; Ravazzolo R; Guenet JL; Puliti A
    Int J Mol Med; 2006 Oct; 18(4):593-600. PubMed ID: 16964410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presynaptic mGlu1 Receptors Control GABA
    Vergassola M; Olivero G; Cisani F; Usai C; Bossi S; Puliti A; Pittaluga A
    Front Mol Neurosci; 2018; 11():324. PubMed ID: 30279647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Group I metabotropic glutamate autoreceptors induce abnormal glutamate exocytosis in a mouse model of amyotrophic lateral sclerosis.
    Giribaldi F; Milanese M; Bonifacino T; Anna Rossi PI; Di Prisco S; Pittaluga A; Tacchetti C; Puliti A; Usai C; Bonanno G
    Neuropharmacology; 2013 Mar; 66():253-63. PubMed ID: 22634363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-Methyl-6-(phenylethynyl)pyridine Hydrochloride Modulates Metabotropic Glutamate 5 Receptors Endogenously Expressed in Zebrafish Brain.
    Albasanz JL; Santana S; Guzman-Sanchez F; León D; Burgos JS; Martín M
    ACS Chem Neurosci; 2016 Dec; 7(12):1690-1697. PubMed ID: 27635438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational analysis and molecular modeling of the binding pocket of the metabotropic glutamate 5 receptor negative modulator 2-methyl-6-(phenylethynyl)-pyridine.
    Malherbe P; Kratochwil N; Zenner MT; Piussi J; Diener C; Kratzeisen C; Fischer C; Porter RH
    Mol Pharmacol; 2003 Oct; 64(4):823-32. PubMed ID: 14500738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the K
    Notartomaso S; Mascio G; Scarselli P; Martinello K; Fucile S; Gradini R; Bruno V; Battaglia G; Nicoletti F
    Neuropharmacology; 2017 Mar; 115():51-59. PubMed ID: 27498071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Albuminuria and glomerular damage in mice lacking the metabotropic glutamate receptor 1.
    Puliti A; Rossi PI; Caridi G; Corbelli A; Ikehata M; Armelloni S; Li M; Zennaro C; Conti V; Vaccari CM; Cassanello M; Calevo MG; Emionite L; Ravazzolo R; Rastaldi MP
    Am J Pathol; 2011 Mar; 178(3):1257-69. PubMed ID: 21356376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticonvulsant activity of two metabotropic glutamate group I antagonists selective for the mGlu5 receptor: 2-methyl-6-(phenylethynyl)-pyridine (MPEP), and (E)-6-methyl-2-styryl-pyridine (SIB 1893).
    Chapman AG; Nanan K; Williams M; Meldrum BS
    Neuropharmacology; 2000 Jul; 39(9):1567-74. PubMed ID: 10854901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactive effects of the mGlu5 receptor antagonist MPEP and the mGlu2/3 receptor antagonist LY341495 on nicotine self-administration and reward deficits associated with nicotine withdrawal in rats.
    Liechti ME; Markou A
    Eur J Pharmacol; 2007 Jan; 554(2-3):164-74. PubMed ID: 17113075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between metabotropic glutamate 5 and adenosine A2A receptors in normal and parkinsonian mice.
    Kachroo A; Orlando LR; Grandy DK; Chen JF; Young AB; Schwarzschild MA
    J Neurosci; 2005 Nov; 25(45):10414-9. PubMed ID: 16280580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the role of metabotropic glutamate receptor 5 in multiple nociceptive modalities.
    Zhu CZ; Wilson SG; Mikusa JP; Wismer CT; Gauvin DM; Lynch JJ; Wade CL; Decker MW; Honore P
    Eur J Pharmacol; 2004 Dec; 506(2):107-18. PubMed ID: 15588730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological enhancement of mGlu1 metabotropic glutamate receptors causes a prolonged symptomatic benefit in a mouse model of spinocerebellar ataxia type 1.
    Notartomaso S; Zappulla C; Biagioni F; Cannella M; Bucci D; Mascio G; Scarselli P; Fazio F; Weisz F; Lionetto L; Simmaco M; Gradini R; Battaglia G; Signore M; Puliti A; Nicoletti F
    Mol Brain; 2013 Nov; 6():48. PubMed ID: 24252411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.